Abdulfattah Y. Alhazmi - Search Results

Year	Number of Results
2023	2
2024	5

1

Humoral and Cellular Immunity following Five Doses of COVID-19 Vaccines in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis.

Alotaibi AS, Shalabi HA, Alhifany AA, Alotaibi NE, Alnuhait MA, Altheaby AR, Alhazmi AY. Alotaibi AS, et al. Among authors: alhazmi ay. Vaccines (Basel). 2023 Jun 27;11(7):1166. doi: 10.3390/vaccines11071166. Vaccines (Basel). 2023. PMID: 37514982 Free PMC article. Review.

2

Unveiling the multitargeted repurposing potential of taxifolin (dihydroquercetin) in cervical cancer: an extensive MM\GBSA-based screening, and MD simulation study.

Almasoudi HH, Hakami MA, Alhazmi AY, Makkawi M, Alasmari S, Alghamdi YS, Mashraqi MM. Almasoudi HH, et al. Among authors: alhazmi ay. Med Oncol. 2023 Jul 2;40(8):218. doi: 10.1007/s12032-023-02094-7. Med Oncol. 2023. PMID: 37394519

3

Delineated 3-1-BenCarMethInYlPro-Phosphonic Acid's Adroit Activity against Lung Cancer through Multitargeted Docking, MM\GBSA, QM-DFT and Multiscale Simulations.

Hakami MA, Hazazi A, Albloui F, Gharib AF, Alsaeedi FA, Abdulaziz O, Alhazmi AY, Alsaiari AA. Hakami MA, et al. Among authors: alhazmi ay. Int J Mol Sci. 2024 Jan 2;25(1):592. doi: 10.3390/ijms25010592. Int J Mol Sci. 2024. PMID: 38203761 Free PMC article.

4

Computational insights into overcoming resistance mechanisms in targeted therapies for advanced breast cancer: focus on EGFR and HER2 co-inhibition.

Abdulaziz O, Khan FR, Alharthi NS, Alhuthali HM, Hazazi A, Alzahrani HA, Gharib AF, Alsalmi OA, Hawsawi NM, Alhazmi AY. Abdulaziz O, et al. Among authors: alhazmi ay. J Biomol Struct Dyn. 2024 Jan 17:1-12. doi: 10.1080/07391102.2024.2301766. Online ahead of print. J Biomol Struct Dyn. 2024. PMID: 38234016

5

In silico assessment of a natural small molecule as an inhibitor of programmed death ligand 1 for cancer immunotherapy: a computational approach.

Alharthi NS, Alwethaynani MS, Alhazmi AY, Alawam AS, Alshehri FF, Alotaibi F, Rehman ZU, Alkhayl FFA, Al-Bazi MM, Khan FR. Alharthi NS, et al. Among authors: alhazmi ay. J Biomol Struct Dyn. 2024 Feb 22:1-21. doi: 10.1080/07391102.2024.2317980. Online ahead of print. J Biomol Struct Dyn. 2024. PMID: 38385444

6

Sakuranetin ameliorates streptozotocin-induced diabetes in rodents by inhibiting caspase-3 activity, modulating hematological parameters, and suppressing inflammatory cytokines: a molecular docking and dynamics study.

Almasoudi HH, Nahari MH, Binshaya AS, Hakami MA, Alhazmi AY, Al Shmrany H, Alqasem A, Khan FR. Almasoudi HH, et al. Among authors: alhazmi ay. J Biomol Struct Dyn. 2024 Mar 9:1-18. doi: 10.1080/07391102.2024.2325659. Online ahead of print. J Biomol Struct Dyn. 2024. PMID: 38459941

7

Structural and energetic analysis of NS5 protein inhibition by small molecules in Japanese encephalitis virus using machine learning and steered molecular dynamics approach.

Alhazmi AY, Khan FR, Rehman ZU, Hazazi A, Alotaibi BS, Alharthi NS, Alhuthali HM, Aba Alkhayl FF, Alshehri FF, Alkhoshaiban A, Al-Otaibi F. Alhazmi AY, et al. J Biomol Struct Dyn. 2024 Feb 26:1-18. doi: 10.1080/07391102.2024.2316767. Online ahead of print. J Biomol Struct Dyn. 2024. PMID: 38407246

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

7 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year